Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Idiopathic Pulmonary Fibrosis International Group Exploring NAC I Annual Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

NCT00639496 is registered in ClinicalTrials.gov with Zambon SpA as lead sponsor.

NCT NCT00639496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Idiopathic Pulmonary Fibrosis International Group Exploring NAC I Annual Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
Lead sponsor
Zambon SpA
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2000
Completion date
July 31, 2003
Enrollment
184 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary fibrosis